Home

TLDR Biotech

The top stories in biotech & pharma, straight to your inbox in only one email.
Trusted by 2700+ biotech and pharma professionals.

Comprehensive daily coverage of the biotech and pharma industry, straight to your inbox.

TLDR Biotech

The Latest Biotech & Pharma Updates

Biotech & Pharma Updates | March 29 - 30, 2026

Mar 31, 2026

•

8 min read

Biotech & Pharma Updates | March 29 - 30, 2026

🧬 Blackstone closes $6.3B fund for life sciences investing and partnerships, Royalty Pharma's $500M investment to Johnson & Johnson to co-fund autoimmune antibody JNJ-4804, FDA approves Biogen's high-dose Spinraza ASO targeting SMN2 for SMA

Anis Fahandej-Sadi

Biotech & Pharma Updates | March 26 - 29, 2026

Mar 30, 2026

•

8 min read

Biotech & Pharma Updates | March 26 - 29, 2026

🧬 Eli Lilly + Insilico Medicine expand AI drug discovery collaboration - $115M upfront + $2.75B total value, AstraZeneca's tozorakimab hits Ph3 endpoints for chronic obstructive pulmonary disease targeting IL-33 pathway, Terrestrial Bio raises $50M Series C - developing microarray patch therapeutic delivery platform

Anis Fahandej-Sadi

Biotech & Pharma Updates | March 25 - 26, 2026

Mar 27, 2026

•

7 min read

Biotech & Pharma Updates | March 25 - 26, 2026

🧬 Pinnacle Medicines raises $89M Series B - advancing oral peptide therapeutics platform, Neion Bio emerges from stealth with egg-based biosimilar partnership to develop three monoclonal antibodies, Insilico Medicine + Tenacia Biotechnology expand AI-driven CNS collaboration with $94.75M deal value

Anis Fahandej-Sadi

Biotech & Pharma Updates | March 24 - 25, 2026

Mar 26, 2026

•

9 min read

Biotech & Pharma Updates | March 24 - 25, 2026

🧬 Merck & Co. to acquire Terns Pharmaceuticals for $6.7B - targeting TERN-701 leukemia drug ahead of Keytruda cliff, Biogen + Alteogen partner on subcutaneous delivery tech - $20M upfront + $559M potential milestones, Denali Therapeutics' Avlayah (tividenofusp alfa-eknm) wins FDA accelerated approval for Hunter syndrome neurologic manifestations

Anis Fahandej-Sadi

Biotech & Pharma Updates | March 23 - 24, 2026

Mar 25, 2026

•

8 min read

Biotech & Pharma Updates | March 23 - 24, 2026

🧬 UCB to build $2B biologics manufacturing facility near Atlanta headquarters, creating 330 jobs, Ocugen advances OCU410 gene therapy targeting RORA to Ph3 for geographic atrophy following positive Ph2 results, Merck & Co. + Quotient Therapeutics partner on IBD drug discovery - $20M upfront + $2.2B milestones

Anis Fahandej-Sadi

Biotech & Pharma Updates | March 22 - 23

Mar 24, 2026

•

8 min read

Biotech & Pharma Updates | March 22 - 23

🧬 Novartis commits $480M to expand manufacturing in Beijing and R&D operations in Shanghai, Oryon Cell Therapies raises $42M Series A - Parkinson's cell therapy replacing dopaminergic neurons, Sanofi + Kali Therapeutics partner on autoimmune tri-specific antibody KT501 - $180M upfront + $1.05B milestones

Anis Fahandej-Sadi

Biotech & Pharma Updates | March 19 - 22, 2026

Mar 23, 2026

•

7 min read

Biotech & Pharma Updates | March 19 - 22, 2026

🧬 Earendil Labs raises $787M funding - AI-powered drugmaker developing biologics for autoimmune conditions and cancer, Novartis acquires Synnovation Therapeutics' Pikavation for $2B upfront to expand PI3Kα breast cancer portfolio, Bristol Myers Squibb's Opdivo (nivolumab) wins FDA approval for treatment-naïve classical Hodgkin lymphoma

Anis Fahandej-Sadi

Biotech & Pharma Updates | March 18 - 19, 2026

Mar 20, 2026

•

8 min read

Biotech & Pharma Updates | March 18 - 19, 2026

🧬 Novo Nordisk's Wegovy HD (semaglutide) wins FDA approval for obesity treatment under priority voucher program, Fauna Bio + Eli Lilly achieve obesity target milestone using hibernation-inspired AI platform - triggers payment, Congruence Therapeutics raises $39.5M financing to advance small molecule correctors pipeline

Anis Fahandej-Sadi

Biotech & Pharma Updates | March 17 - 18, 2026

Mar 19, 2026

•

8 min read

Biotech & Pharma Updates | March 17 - 18, 2026

🧬 Crossbow Therapeutics raises $77M Series B - developing next-generation cancer immunotherapies, TerraPower commits $450M to build Philadelphia radioisotope production plant - boosting actinium-225 capacity 20-fold, Johnson & Johnson's Icotyde (icotrokinra) wins FDA approval for moderate-to-severe plaque psoriasis targeting interleukin-23

Anis Fahandej-Sadi

...

The Latest Biotech & Pharma Updates

Biotech & Pharma Updates | March 29 - 30, 2026

Biotech & Pharma Updates | March 26 - 29, 2026

Biotech & Pharma Updates | March 25 - 26, 2026

Biotech & Pharma Updates | March 24 - 25, 2026

Biotech & Pharma Updates | March 23 - 24, 2026

Biotech & Pharma Updates | March 22 - 23

Biotech & Pharma Updates | March 19 - 22, 2026

Biotech & Pharma Updates | March 18 - 19, 2026

Biotech & Pharma Updates | March 17 - 18, 2026

TLDR Biotech

FAQ

Media Partners